Cytokinesis and cancer

FEBS Letters

Volumn 584, Issue 12, 2010, Pages 2652-2661

  Sagona, Antonia P ^a,b   Stenmark, Harald ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Abscission; Cancer; Cell division; Cytokinesis; Midbody

Indexed keywords

ANTINEOPLASTIC AGENT; CELL PROTEIN; CHECKPOINT KINASE 1 INHIBITOR; KINESIN; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN DERIVATIVE; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANAPHASE; APOPTOSIS; BLADDER CANCER; BREAST CANCER; BREAST CARCINOGENESIS; CANCER STAGING; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL CYCLE REGULATION; CELL DIVISION; CELL FUSION; CELL MATURATION; CELL STRESS; CHROMOSOME ABERRATION; CLINICAL TRIAL; CYTOKINESIS; CYTOSKELETON; DAUGHTER CELL; DEVELOPMENTAL STAGE; DNA DAMAGE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MITOSIS; NEUROECTODERM TUMOR; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SQUAMOUS CELL CARCINOMA; TETRAPLOIDY;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CYTOKINESIS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MITOSIS; MODELS, BIOLOGICAL; NEOPLASMS; POLYPLOIDY; PROTEIN KINASES;

MAMMALIA;

EID: 77953128969     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.03.044     Document Type: Review

References (83)

1. Eggert U.S., Mitchison T.J., Field C.M. Animal cytokinesis: from parts list to mechanisms. Annu. Rev. Biochem. 2006, 75:543-566.
2. Glotzer M. The molecular requirements for cytokinesis. Science 2005, 307:1735-1739.
3. Fujiwara T., Bandi M., Nitta M., Ivanova E.V., Bronson R.T., Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 2005, 437:1043-1047.
4. Ganem N.J., Storchova Z., Pellman D. Tetraploidy, aneuploidy and cancer. Curr. Opin. Genet. Dev. 2007, 17:157-162.
5. Steigemann P., Wurzenberger C., Schmitz M.H., Held M., Guizetti J., Maar S., Gerlich D.W. Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell 2009, 136:473-484.
6. Caldwell C.M., Green R.A., Kaplan K.B. APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice. J. Cell Biol. 2007, 178:1109-1120.
7. Boveri T. Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J. Cell Sci. 2008, 121(Suppl. 1):1-84.
8. Uetake Y., Sluder G. Cell cycle progression after cleavage failure: mammalian somatic cells do not possess a " tetraploidy checkpoint" J. Cell Biol. 2004, 165:609-615.
9. Jallepalli P.V., Lengauer C. Chromosome segregation and cancer: cutting through the mystery. Nat. Rev. Cancer 2001, 1:109-117.
10. Rappaport R. Cytokinesis in animal cells. Int. Rev. Cytol. 1971, 31:169-213.
11. Steigemann P., Gerlich D.W. Cytokinetic abscission: cellular dynamics at the midbody. Trends Cell Biol. 2009, 19:606-616.
12. Glotzer M. The 3Ms of central spindle assembly: microtubules, motors and MAPs. Nat. Rev. Mol. Cell Biol. 2009, 10:9-20.
13. Mollinari C., Kleman J.P., Jiang W., Schoehn G., Hunter T., Margolis R.L. PRC1 is a microtubule binding and bundling protein essential to maintain the mitotic spindle midzone. J. Cell Biol. 2002, 157:1175-1186.
14. Zhu C., Lau E., Schwarzenbacher R., Bossy-Wetzel E., Jiang W. Spatiotemporal control of spindle midzone formation by PRC1 in human cells. Proc. Natl. Acad. Sci. USA 2006, 103:6196-6201.
15. Mishima M., Kaitna S., Glotzer M. Central spindle assembly and cytokinesis require a kinesin-like protein/RhoGAP complex with microtubule bundling activity. Dev. Cell 2002, 2:41-54.
16. Jeyaprakash A.A., Klein U.R., Lindner D., Ebert J., Nigg E.A., Conti E. Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together. Cell 2007, 131:271-285.
17. Hummer S., Mayer T.U. Cdk1 negatively regulates midzone localization of the mitotic kinesin Mklp2 and the chromosomal passenger complex. Curr. Biol. 2009, 19:607-612.
18. Raemaekers T., Ribbeck K., Beaudouin J., Annaert W., Van C.M., Stockmans I., Smets N., Bouillon R., Ellenberg J., Carmeliet G. NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization. J. Cell Biol. 2003, 162:1017-1029.
19. Maiato H., Sampaio P., Lemos C.L., Findlay J., Carmena M., Earnshaw W.C., Sunkel C.E. MAST/orbit has a role in microtubule-kinetochore attachment and is essential for chromosome alignment and maintenance of spindle bipolarity. J. Cell Biol. 2002, 157:749-760.
20. Gonzalez C., Saunders R.D., Casal J., Molina I., Carmena M., Ripoll P., Glover D.M. Mutations at the asp locus of Drosophila lead to multiple free centrosomes in syncytial embryos, but restrict centrosome duplication in larval neuroblasts. J. Cell Sci. 1990, 96(Pt 4):605-616.
21. Fanarraga M.L., Bellido J., Jaen C., Villegas J.C., Zabala J.C. TBCD links centriologenesis, spindle microtubule dynamics, and midbody abscission in human cells. PLoS One 2010, 5:e8846.
22. Abaza A., Soleilhac J.M., Westendorf J., Piel M., Crevel I., Roux A., Pirollet F. M phase phosphoprotein 1 is a human plus-end-directed kinesin-related protein required for cytokinesis. J. Biol. Chem. 2003, 278:27844-27852.
23. Gruneberg U., Neef R., Li X., Chan E.H., Chalamalasetty R.B., Nigg E.A., Barr F.A. KIF14 and citron kinase act together to promote efficient cytokinesis. J. Cell Biol. 2006, 172:363-372.
24. Yuce O., Piekny A., Glotzer M. An ECT2-centralspindlin complex regulates the localization and function of RhoA. J. Cell Biol. 2005, 170:571-582.
25. Simon G.C., Schonteich E., Wu C.C., Piekny A., Ekiert D., Yu X., Gould G.W., Glotzer M., Prekeris R. Sequential Cyk-4 binding to ECT2 and FIP3 regulates cleavage furrow ingression and abscission during cytokinesis. EMBO J. 2008, 27:1791-1803.
26. Neef R., Preisinger C., Sutcliffe J., Kopajtich R., Nigg E.A., Mayer T.U., Barr F.A. Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis. J. Cell Biol. 2003, 162:863-875.
27. Petronczki M., Glotzer M., Kraut N., Peters J.M. Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle. Dev. Cell 2007, 12:713-725.
28. Joo E., Tsang C.W., Trimble W.S. Septins: traffic control at the cytokinesis intersection. Traffic 2005, 6:626-634.
29. Hickson G.R., O'Farrell P.H. Anillin: a pivotal organizer of the cytokinetic machinery. Biochem. Soc. Trans. 2008, 36:439-441.
30. Zhao W.M., Seki A., Fang G. Cep55, a microtubule-bundling protein, associates with centralspindlin to control the midbody integrity and cell abscission during cytokinesis. Mol. Biol. Cell 2006, 17:3881-3896.
31. Carlton J.G., Martin-Serrano J. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 2007, 316:1908-1912.
32. Raiborg C., Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 2009, 458:445-452.
33. Yang D., Rismanchi N., Renvoise B., Lippincott-Schwartz J., Blackstone C., Hurley J.H. Structural basis for midbody targeting of spastin by the ESCRT-III protein CHMP1B. Nat. Struct. Mol. Biol. 2008, 15:1278-1286.
34. Sagona A.P., Nezis I.P., Pedersen N.M., Liestol K., Poulton J., Rusten T.E., Skotheim R.I., Raiborg C., Stenmark H. PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody. Nat. Cell Biol. 2010, 12:362-371.
35. Storchova Z., Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell Biol. 2004, 5:45-54.
36. Ogle B.M., Cascalho M., Platt J.L. Biological implications of cell fusion. Nat. Rev. Mol. Cell Biol. 2005, 6:567-575.
37. Edgar B.A., Orr-Weaver T.L. Endoreplication cell cycles: more for less. Cell 2001, 105:297-306.
38. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression?. Nat. Rev. Cancer 2002, 2:815-825.
39. Peddibhotla S., Lam M.H., Gonzalez-Rimbau M., Rosen J.M. The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis. Proc. Natl. Acad. Sci. USA 2009, 106:5159-5164.
40. Weaver B.A., Cleveland D.W. The role of aneuploidy in promoting and suppressing tumors. J. Cell Biol. 2009, 185:935-937.
41. Andreassen P.R., Lohez O.D., Lacroix F.B., Margolis R.L. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol. Biol. Cell 2001, 12:1315-1328.
42. Wong C., Stearns T. Mammalian cells lack checkpoints for tetraploidy, aberrant centrosome number, and cytokinesis failure. BMC Cell Biol. 2005, 6:6.
43. Stukenberg P.T. Triggering p53 after cytokinesis failure. J. Cell Biol. 2004, 165:607-608.
44. Varmark H., Sparks C.A., Nordberg J.J., Koppetsch B.S., Theurkauf W.E. DNA damage-induced cell death is enhanced by progression through mitosis. Cell Cycle 2009, 8:2951-2963.
45. Lingle W.L., Lutz W.H., Ingle J.N., Maihle N.J., Salisbury J.L. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc. Natl. Acad. Sci. USA 1998, 95:2950-2955.
46. Lingle W.L., Barrett S.L., Negron V.C., D'Assoro A.B., Boeneman K., Liu W., Whitehead C.M., Reynolds C., Salisbury J.L. Centrosome amplification drives chromosomal instability in breast tumor development. Proc. Natl. Acad. Sci. USA 2002, 99:1978-1983.
47. Pihan G.A., Purohit A., Wallace J., Malhotra R., Liotta L., Doxsey S.J. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res. 2001, 61:2212-2219.
48. Yamamoto Y., Eguchi S., Junpei A., Nagao K., Sakano S., Furuya T., Oga A., Kawauchi S., Sasaki K., Matsuyama H. Intercellular centrosome number is correlated with the copy number of chromosomes in bladder cancer. Cancer Genet. Cytogenet. 2009, 191:38-42.
49. Kuo K.K., Sato N., Mizumoto K., Maehara N., Yonemasu H., Ker C.G., Sheen P.C., Tanaka M. Centrosome abnormalities in human carcinomas of the gallbladder and intrahepatic and extrahepatic bile ducts. Hepatology 2000, 31:59-64.
50. Sato N., Mizumoto K., Nakamura M., Nakamura K., Kusumoto M., Niiyama H., Ogawa T., Tanaka M. Centrosome abnormalities in pancreatic ductal carcinoma. Clin. Cancer Res. 1999, 5:963-970.
51. Gustafson L.M., Gleich L.L., Fukasawa K., Chadwell J., Miller M.A., Stambrook P.J., Gluckman J.L. Centrosome hyperamplification in head and neck squamous cell carcinoma: a potential phenotypic marker of tumor aggressiveness. Laryngoscope 2000, 110:1798-1801.
52. Carroll P.E., Okuda M., Horn H.F., Biddinger P., Stambrook P.J., Gleich L.L., Li Y.Q., Tarapore P., Fukasawa K. Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression. Oncogene 1999, 18:1935-1944.
53. Thirthagiri E., Robinson C.M., Huntley S., Davies M., Yap L.F., Prime S.S., Paterson I.C. Spindle assembly checkpoint and centrosome abnormalities in oral cancer. Cancer Lett. 2007, 258:276-285.
54. Weber R.G., Bridger J.M., Benner A., Weisenberger D., Ehemann V., Reifenberger G., Lichter P. Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations. Cytogenet. Cell Genet. 1998, 83:266-269.
55. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. P53 mutations in human cancers. Science 1991, 253:49-53.
56. Wilker E.W., van Vugt M.A., Artim S.A., Huang P.H., Petersen C.P., Reinhardt H.C., Feng Y., Sharp P.A., Sonenberg N., White F.M., Yaffe M.B. 14-3-3sigma controls mitotic translation to facilitate cytokinesis. Nature 2007, 446:329-332.
57. Lee Y.H., Oh B.K., Yoo J.E., Yoon S.M., Choi J., Kim K.S., Park Y.N. Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis. Mod. Pathol. 2009, 22:1121-1131.
58. Li Y., Benezra R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 1996, 274:246-248.
59. Cahill D.P., Lengauer C., Yu J., Riggins G.J., Willson J.K., Markowitz S.D., Kinzler K.W., Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature 1998, 392:300-303.
60. Cheng C.K., Chow L.W., Loo W.T., Chan T.K., Chan V. The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer. Cancer Res. 2005, 65:8646-8654.
61. Boultwood J. Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J. Clin. Pathol. 2001, 54:512-516.
62. Tort F., Hernandez S., Bea S., Camacho E., Fernandez V., Esteller M., Fraga M.F., Burek C., Rosenwald A., Hernandez L., Campo E. Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms. Leukemia 2005, 19:112-117.
63. Kato N., Fujimoto H., Yoda A., Oishi I., Matsumura N., Kondo T., Tsukada J., Tanaka Y., Imamura M., Minami Y. Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines. Cell Death Differ. 2004, 11(Suppl. 2):S153-S161.
64. Bell D.W., Varley J.M., Szydlo T.E., Kang D.H., Wahrer D.C., Shannon K.E., Lubratovich M., Verselis S.J., Isselbacher K.J., Fraumeni J.F., Birch J.M., Li F.P., Garber J.E., Haber D.A. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science 1999, 286:2528-2531.
65. Bartkova J., Guldberg P., Gronbaek K., Koed K., Primdahl H., Moller K., Lukas J., Orntoft T.F., Bartek J. Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer. Oncogene 2004, 23:8545-8551.
66. Mariatos G., Bothos J., Zacharatos P., Summers M.K., Scolnick D.M., Kittas C., Halazonetis T.D., Gorgoulis V.G. Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer. Cancer Res. 2003, 63:7185-7189.
67. Chaplet M., Rai R., Jackson-Bernitsas D., Li K., Lin S.Y. BRIT1/MCPH1: a guardian of genome and an enemy of tumors. Cell Cycle 2006, 5:2579-2583.
68. Liu M., Shen S., Chen F., Yu W., Yu L. Linking the septin expression with carcinogenesis 2010, Mol, Biol Rep.
69. Zhang L., Maddox A.S. Anillin. Curr. Biol. 2010, 20:R135-R136.
70. Yun M.H., Hiom K. Understanding the functions of BRCA1 in the DNA-damage response. Biochem. Soc. Trans. 2009, 37:597-604.
71. Lo V.V., Calabrese G., Manzoli L., Palka G., Spadano A., Morizio E., Guanciali-Franchi P., Fantasia D., Cocco L. Inositide-specific phospholipase c β1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia. Leukemia 2004, 18:1122-1126.
72. Vecchione A., Croce C.M., Baldassarre G. Fez1/Lzts1 a new mitotic regulator implicated in cancer development. Cell Div. 2007, 2:24.
73. Song L., Dai T., Xiong H., Lin C., Lin H., Shi T., Li J. Inhibition of centriole duplication by centrobin depletion leads to p38-p53 mediated cell-cycle arrest. Cell Signal. 2010.
74. Li C.C., Chu H.Y., Yang C.W., Chou C.K., Tsai T.F. Aurora-A overexpression in mouse liver causes p53-dependent premitotic arrest during liver regeneration. Mol. Cancer Res. 2009, 7:678-688.
75. You J., Li Q., Wu C., Kim J., Ottinger M., Howley P.M. Regulation of aurora B expression by the bromodomain protein Brd4. Mol. Cell Biol. 2009, 29:5094-5103.
76. Zhou H., Kuang J., Zhong L., Kuo W.L., Gray J.W., Sahin A., Brinkley B.R., Sen S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 1998, 20:189-193.
77. Ikezoe T., Yang J., Nishioka C., Takezaki Y., Tasaka T., Togitani K., Koeffler H.P., Yokoyama A. A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies. Leukemia 2009, 23:1564-1576.
78. Madhavan J., Mitra M., Mallikarjuna K., Pranav O., Srinivasan R., Nagpal A., Venkatesan P., Kumaramanickavel G. KIF14 and E2F3 mRNA expression in human retinoblastoma and its phenotype association. Mol. Vis. 2009, 15:235-240.
79. Pellinen T., Tuomi S., Arjonen A., Wolf M., Edgren H., Meyer H., Grosse R., Kitzing T., Rantala J.K., Kallioniemi O., Fassler R., Kallio M., Ivaska J. Integrin trafficking regulated by Rab21 is necessary for cytokinesis. Dev. Cell 2008, 15:371-385.
80. Salipante S.J., Mealiffe M.E., Wechsler J., Krem M.M., Liu Y., Namkoong S., Bhagat G., Kirchhoff T., Offit K., Lynch H., Wiernik P.H., Roshal M., McMaster M.L., Tucker M., Fromm J.R., Goldin L.R., Horwitz M.S. Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells. Proc. Natl. Acad. Sci. USA 2009, 106:14920-14925.
81. Cai K.Q., Caslini C., Capo-chichi C.D., Slater C., Smith E.R., Wu H., Klein-Szanto A.J., Godwin A.K., Xu X.X. Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia. PLoS One 2009, 4:e6454.
82. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K., Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., Velculescu V.E. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
83. Bucher N., Britten C.D. G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br. J. Cancer 2008, 98:523-528.